Epitomee Medical Ltd (EPIT.TA)
ILA 1060.0
(2.42%)
ILA 1060.0
(2.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 10 Million USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -731.74 Thousand ILA | 0.0% |
| 2024 Q1 | - ILA | -100.0% |
| 2023 Q3 | 1.9 Billion ILA | 159985.89% |
| 2023 FY | 10 Million USD | 0.0% |
| 2023 Q1 | - ILA | 100.0% |
| 2023 Q2 | -1.19 Million ILA | 0.0% |
| 2023 Q4 | 1.8 Billion ILA | -5.31% |
| 2022 FY | - USD | 0.0% |
| 2022 Q2 | -540.19 Thousand ILA | 0.0% |
| 2022 Q4 | -657.92 Thousand ILA | 0.0% |
| 2022 Q3 | - ILA | 100.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q4 | - ILA | 0.0% |
| 2021 Q2 | -365.97 Thousand ILA | 0.0% |
| 2020 Q2 | -392.5 Thousand ILA | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2020 Q4 | -394.88 Thousand ILA | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|